Annual Operating Expenses
$142.06 M
+$5.70 M+4.18%
31 December 2023
Summary:
Foghorn Therapeutics annual total operating expenses is currently $142.06 million, with the most recent change of +$5.70 million (+4.18%) on 31 December 2023. During the last 3 years, it has risen by +$73.10 million (+106.00%). FHTX annual operating expenses is now at all-time high.FHTX Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$31.66 M
+$538.00 K+1.73%
30 September 2024
Summary:
Foghorn Therapeutics quarterly total operating expenses is currently $31.66 million, with the most recent change of +$538.00 thousand (+1.73%) on 30 September 2024. Over the past year, it has dropped by -$2.90 million (-8.39%). FHTX quarterly operating expenses is now -18.03% below its all-time high of $38.63 million, reached on 31 March 2023.FHTX Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FHTX Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +4.2% | -8.4% |
| 3 y3 years | +106.0% | +20.4% |
| 5 y5 years | +445.4% | +141.7% |
FHTX Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +106.0% | -18.0% | +20.4% |
| 5 y | 5 years | at high | +445.4% | -18.0% | +141.7% |
| alltime | all time | at high | +445.4% | -18.0% | +141.7% |
Foghorn Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $31.66 M(+1.7%) |
| June 2024 | - | $31.12 M(-6.4%) |
| Mar 2024 | - | $33.24 M(+6.5%) |
| Dec 2023 | $142.06 M(+4.2%) | $31.23 M(-9.6%) |
| Sept 2023 | - | $34.56 M(-8.2%) |
| June 2023 | - | $37.65 M(-2.5%) |
| Mar 2023 | - | $38.63 M(+7.1%) |
| Dec 2022 | $136.37 M(+33.6%) | $36.07 M(+3.4%) |
| Sept 2022 | - | $34.89 M(+3.6%) |
| June 2022 | - | $33.68 M(+6.2%) |
| Mar 2022 | - | $31.72 M(+10.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $102.05 M(+48.0%) | $28.80 M(+9.5%) |
| Sept 2021 | - | $26.30 M(+11.7%) |
| June 2021 | - | $23.54 M(+0.5%) |
| Mar 2021 | - | $23.42 M(+11.3%) |
| Dec 2020 | $68.96 M(+35.0%) | $21.03 M(+12.7%) |
| Sept 2020 | - | $18.67 M(+20.1%) |
| June 2020 | - | $15.54 M(+13.2%) |
| Mar 2020 | - | $13.72 M(-9.6%) |
| Dec 2019 | $51.08 M(+96.1%) | $15.19 M(+15.9%) |
| Sept 2019 | - | $13.10 M |
| Dec 2018 | $26.05 M | - |
FAQ
- What is Foghorn Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Foghorn Therapeutics?
- What is Foghorn Therapeutics annual operating expenses year-on-year change?
- What is Foghorn Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Foghorn Therapeutics?
- What is Foghorn Therapeutics quarterly operating expenses year-on-year change?
What is Foghorn Therapeutics annual total operating expenses?
The current annual operating expenses of FHTX is $142.06 M
What is the all time high annual operating expenses for Foghorn Therapeutics?
Foghorn Therapeutics all-time high annual total operating expenses is $142.06 M
What is Foghorn Therapeutics annual operating expenses year-on-year change?
Over the past year, FHTX annual total operating expenses has changed by +$5.70 M (+4.18%)
What is Foghorn Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of FHTX is $31.66 M
What is the all time high quarterly operating expenses for Foghorn Therapeutics?
Foghorn Therapeutics all-time high quarterly total operating expenses is $38.63 M
What is Foghorn Therapeutics quarterly operating expenses year-on-year change?
Over the past year, FHTX quarterly total operating expenses has changed by -$2.90 M (-8.39%)